Transplantation in the EU: From the waiting lists to post-transplantation journey

Medical technology innovation and policy advancements are improving the transplantation experience for thousands of people in the European Union.

Euractiv's Advocacy Lab
Team,Of,Surgeon,Doctors,Are,Performing,Heart,Surgery,Operation,For
Solid organ & stem cell transplants are life-saving option for many patients. [<a href="https://www.shutterstock.com/image-photo/team-surgeon-doctors-performing-heart-surgery-2161715437" target="_blank" rel="noopener">[SHUTTERSTOCK/Akarawut]</a>]
Medical technology innovation and policy advancements are improving the transplantation experience for thousands of people in the European Union.
At the same time, issues such as organ shortages and long waiting lists need political action, as well as further steps in cross-border coordination and differences among different member states not only on transplantation, but also on a post-transplantation journey. A common approach amongst EU countries on how to look after eventual post-transplant complications and treatment is one of today’s pressing issues.
In this series of articles, Euractiv looks at the state of solid organ, but also stem cell and bone marrow, transplantation in the EU, with a keen eye on the importance of living donors and post-transplant care.
Organ donation needs a new roadmap, says MEP Nevado del Campo
Transplant patients need a survivors’ support framework, say health experts
Renewed EU transplant plan must adapt to demographics and patient journeys
EU lacks cross border cooperation in access to transplants, experts warn
Stem cell transplant risks mitigated with stem cell therapies
Back to the future: Regenerating organs in the fight against shortages
Gut bacteria can be the key to safer stem cell transplantations, study finds
Why a successful transplant is only half the patient journey